Waldemar Priebe - May 5, 2020 Form 4 Insider Report for CNS Pharmaceuticals, Inc. (CNSP)

Role
10%+ Owner
Signature
/s/ Waldemar Priebe
Stock symbol
CNSP
Transactions as of
May 5, 2020
Transactions value $
$0
Form type
4
Date filed
1/25/2022, 03:05 PM
Next filing
Aug 1, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CNSP Common Stock Other -1.5M -16.57% 7.53M May 5, 2020 See footnote F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares are held by a limited liability company for which the reporting person's adult child is the sole manager and adult children are sole members. Prior to May 5, 2020, the reporting person was a manager of the limited liability company. The reporting person ceased to be a manager of the limited liability company on May 5, 2020, and since such date has not had any voting or dispositive power over the shares held by the limited liability company. The reporting person has never had a pecuniary interest in the limited liability company.
F2 Consists of: (i) 7,333,133 shares of common stock held by a limited liability company; and (ii) 200,000 shares held by Houston Pharmaceuticals, Inc.